Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIFE: Levomilnacipran for functional recovery in ischemic stroke
NCT01639014Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Jul 2012
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of levomilnacipran in ischemic stroke, sponsored by Pierre Fabre Laboratories. Started Jul 2012; status: completed.
02
Drugs
levomilnacipran
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01639014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01639014.